Celcuity (CELC) Enterprise Value Growth (3y) (2019 - 2025)
Celcuity (CELC) Enterprise Value Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Celcuity | 4.13 Bn | 4.13 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -62.04% |
| Sep 30, 2025 | -99.26% |
| Jun 30, 2025 | -36.01% |
| Mar 31, 2025 | -37.97% |
| Dec 31, 2024 | -40.75% |
| Sep 30, 2024 | -42.95% |
| Jun 30, 2024 | -89.40% |
| Mar 31, 2024 | -71.93% |
| Dec 31, 2023 | -149.26% |
| Sep 30, 2023 | -113.73% |
| Jun 30, 2023 | -111.52% |
| Mar 31, 2023 | -110.53% |
| Dec 31, 2022 | -107.92% |
| Sep 30, 2022 | -41.15% |
| Jun 30, 2022 | -64.85% |
| Mar 31, 2022 | -74.47% |
| Dec 31, 2021 | -74.13% |
| Sep 30, 2021 | -58.36% |
| Jun 30, 2021 | -24.56% |
| Mar 31, 2021 | -137.78% |